|
1
|
Roffo AH: Heliotropism of cholesterol in
relation to skin cancer. Am J Cancer. 17:42–57. 1933. View Article : Google Scholar
|
|
2
|
Yasuda M and Bloor WR: Lipid content of
tumors. J Clin Invest. 11:677–682. 1932. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gebhard RL, Clayman RV, Prigge WF,
Figenshau R, Staley NA, Reesey C and Bear A: Abnormal cholesterol
metabolism in renal clear cell carcinoma. J Lipid Res.
28:1177–1184. 1987.PubMed/NCBI
|
|
4
|
Rudel LL, Lee RG and Cockman TL: Acyl
coenzyme A: Cholesterol acyltransferase types 1 and 2: Structure
and function in atherosclerosis. Curr Opin Lipidol. 12:121–127.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang TY, Chang CC and Cheng D:
Acyl-coenzyme A: Cholesterol acyltransferase. Annu Rev Biochem.
66:613–638. 1997. View Article : Google Scholar
|
|
6
|
Sakashita N, Miyazaki A, Takeya M,
Horiuchi S, Chang CC, Chang TY and Takahashi K: Localization of
human acyl-coenzyme a: Cholesterol acyltransferase-1 (ACAT-1) in
macrophages and in various tissues. Am J Pathol. 156:227–236. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nygren C, von Holst H, Månsson JE and
Fredman P: Increased levels of cholesterol esters in glioma tissue
and surrounding areas of human brain. Br J Neurosurg. 11:216–220.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fredman P, von Holst H, Collins VP, Ammar
A, Dellheden B, Wahren B, Granholm L and Svennerholm L: Potential
ganglioside antigens associated with human gliomas. Neurol Res.
8:123–126. 1986.PubMed/NCBI
|
|
9
|
Kaba SE and Kyritsis AP: Recognition and
management of gliomas. Drugs. 53:235–244. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ikenoya M, Yoshinaka Y, Kobayashi H,
Kawamine K, Shibuya K, Sato F, Sawanobori K, Watanabe T and
Miyazaki A: A selective ACAT-1 inhibitor, K-604, suppresses fatty
streak lesions in fat-fed hamsters without affecting plasma
cholesterol levels. Atherosclerosis. 191:290–297. 2007. View Article : Google Scholar
|
|
12
|
García-Regalado A, Guzmán-Hernández ML,
Ramírez-Rangel I, Robles-Molina E, Balla T, Vázquez-Prado J and
Reyes-Cruz G: G protein-coupled receptor-promoted trafficking of
Gbeta1gamma2 leads to AKT activation at endosomes via a mechanism
mediated by Gbeta1gamma2-Rab11a interaction. Mol Biol Cell.
19:4188–4200. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bemlih S, Poirier MD and El Andaloussi A:
Acyl-coenzyme A: cholesterol acyltransferase inhibitor Avasimibe
affect survival and proliferation of glioma tumor cell lines.
Cancer Biol Ther. 9:1025–1032. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang CC, Chen J, Thomas MA, Cheng D, Del
Priore VA, Newton RS, Pape ME and Chang TY: Regulation and
immunolocalization of acyl-coenzyme A: Cholesterol acyltransferase
in mammalian cells as studied with specific antibodies. J Biol
Chem. 270:29532–29540. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niikura Y, Nonaka T and Imajoh-Ohmi S:
Monitoring of caspase-8/FLICE processing and activation upon Fas
stimulation with novel antibodies directed against a cleavage site
for caspase-8 and its substrate, FLICE-like inhibitory protein
(FLIP). J Biochem. 132:53–62. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lawlor MA and Alessi DR: PKB/Akt: A key
mediator of cell proliferation, survival and insulin responses? J
Cell Sci. 114:2903–2910. 2001.PubMed/NCBI
|
|
20
|
Chakravarti A, Zhai G, Suzuki Y, Sarkesh
S, Black PM, Muzikansky A and Loeffler JS: The prognostic
significance of phosphatidylinositol 3-kinase pathway activation in
human gliomas. J Clin Oncol. 22:1926–1933. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lopez-Gines C, Gil-Benso R, Benito R, Mata
M, Pereda J, Sastre J, Roldan P, Gonzalez-Darder J and
Cerdá-Nicolás M: The activation of ERK1/2 MAP kinases in
glioblastoma pathobiology and its relationship with EGFR
amplification. Neuropathology. 28:507–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burnett JR, Wilcox LJ, Telford DE,
Kleinstiver SJ, Barrett PH, Newton RS and Huff MW: Inhibition of
ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B
production in miniature pigs. J Lipid Res. 40:1317–1327.
1999.PubMed/NCBI
|
|
23
|
Delsing DJ, Offerman EH, van Duyvenvoorde
W, van Der Boom H, de Wit EC, Gijbels MJ, van Der Laarse A, Jukema
JW, Havekes LM and Princen HM: Acyl-CoA:Cholesterol acyltransferase
inhibitor avasimibe reduces atherosclerosis in addition to its
cholesterol-lowering effect in ApoE*3-Leiden mice.
Circulation. 103:1778–1786. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng CK, Fan QW and Weiss WA: PI3K
signaling in glioma-animal models and therapeutic challenges. Brain
Pathol. 19:112–120. 2009. View Article : Google Scholar :
|
|
25
|
Robinson JP, Vanbrocklin MW, McKinney AJ,
Gach HM and Holmen SL: Akt signaling is required for glioblastoma
maintenance in vivo. Am J Cancer Res. 1:155–167. 2011.PubMed/NCBI
|
|
26
|
Gallia GL, Tyler BM, Hann CL, Siu IM,
Giranda VL, Vescovi AL, Brem H and Riggins GJ: Inhibition of Akt
inhibits growth of glioblastoma and glioblastoma stem-like cells.
Mol Cancer Ther. 8:386–393. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reddy KB, Nabha SM and Atanaskova N: Role
of MAP kinase in tumor progression and invasion. Cancer Metastasis
Rev. 22:395–403. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen D, Zuo D, Luan C, Liu M, Na M, Ran L,
Sun Y, Persson A, Englund E and Salford LG: Glioma cell
proliferation controlled by ERK activity-dependent surface
expression of PDGFRA. PLoS One. 9:e872812014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhuang L, Lin J, Lu ML, Solomon KR and
Freeman MR: Cholesterol-rich lipid rafts mediate akt-regulated
survival in prostate cancer cells. Cancer Res. 62:2227–2231.
2002.PubMed/NCBI
|
|
30
|
Ringerike T, Blystad FD, Levy FO, Madshus
IH and Stang E: Cholesterol is important in control of EGF receptor
kinase activity but EGF receptors are not concentrated in caveolae.
J Cell Sci. 115:1331–1340. 2002.PubMed/NCBI
|
|
31
|
Linder ME and Deschenes RJ:
Palmitoylation: Policing protein stability and traffic. Nat Rev Mol
Cell Biol. 8:74–84. 2007. View
Article : Google Scholar
|
|
32
|
Bhattacharyya R, Barren C and Kovacs DM:
Palmitoylation of amyloid precursor protein regulates amyloidogenic
processing in lipid rafts. J Neurosci. 33:11169–11183. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Knüpfer MM, Poppenborg H, Hotfilder M,
Kühnel K, Wolff JE and Domula M: CD44 expression and hyaluronic
acid binding of malignant glioma cells. Clin Exp Metastasis.
17:71–76. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei KC, Huang CY, Chen PY, Feng LY, Wu TW,
Chen SM, Tsai HC, Lu YJ, Tsang NM, Tseng CK, et al: Evaluation of
the prognostic value of CD44 in glioblastoma multiforme. Anticancer
Res. 30:253–259. 2010.PubMed/NCBI
|
|
35
|
Ponta H, Sherman L and Herrlich PA: CD44:
From adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oliferenko S, Paiha K, Harder T, Gerke V,
Schwärzler C, Schwarz H, Beug H, Günthert U and Huber LA: Analysis
of CD44-containing lipid rafts: Recruitment of annexin II and
stabilization by the actin cytoskeleton. J Cell Biol. 146:843–854.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Subramaniam V, Vincent IR, Gardner H, Chan
E, Dhamko H and Jothy S: CD44 regulates cell migration in human
colon cancer cells via Lyn kinase and AKT phosphorylation. Exp Mol
Pathol. 83:207–215. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park YS, Huh JW, Lee JH and Kim HR: shRNA
against CD44 inhibits cell proliferation, invasion and migration
and promotes apoptosis of colon carcinoma cells. Oncol Rep.
27:339–346. 2012.
|
|
39
|
Huang LH, Gui J, Artinger E, Craig R,
Berwin BL, Ernst PA, Chang CC and Chang TY: Acat1 gene ablation in
mice increases hematopoietic progenitor cell proliferation in bone
marrow and causes leukocytosis. Arterioscler Thromb Vasc Biol.
33:2081–2087. 2013. View Article : Google Scholar : PubMed/NCBI
|
